Defining the clinical phenotype of COVID-19 in children

Autor:	Vania Giacomet, Laura Paradiso, Marta Stracuzzi, Maria Elisabetta Di Cosimo, Valeria Rubinacci, Gian Vincenzo Zuccotti
Rok vydání:	2020
Předmět:	Pediatrics medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Immunology Disease Disease cluster medicine.disease_cause SARS‐CoV‐2 Covid‐19 in Children and Adolescents 2020 Update from The Italian Society of Pediatric Allergy and Immunology children COVID‐19 Pandemic medicine Immunology and Allergy Humans Pediatrics Perinatology and Child Health Clinical phenotype Child Coronavirus business.industry SARS-CoV-2 COVID-19 medicine.disease COVID-19 Drug Treatment Pneumonia Phenotype Italy Pediatrics Perinatology and Child Health Supplement Article business
Zdroj:	Pediatric Allergy and Immunology
ISSN:	1399-3038
Popis:	On January 7, 2020, a novel coronavirus (SARS‐CoV‐2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS‐CoV‐2 discovery, the corresponding disease (COVID‐19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID‐19 had been confirmed worldwide, with more than 318.599 deaths.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0ffa768c536158d10531ae157197b7 https://pubmed.ncbi.nlm.nih.gov/33236440 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.